1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. BAL PHARMA LTD.

Bal Pharma Ltd. NSE: BALPHARMA | BSE: 524824

Bal Pharma Ltd. Live Share Price Today, Share Analysis and Chart

Value Stock, Under Radar
about

Bal Pharma is engaged in the manufacturing and selling of pharmaceutical products.

Read More

98.13 0.84 (0.86%)

37.88% Fall from 52W High

43,827 NSE+BSE Volume

NSE 03 Jun, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
60.0 / 100
Valuation Score
Affordable Valuation
57.7 / 100
Momentum Score
Technically Bearish
30.8 / 100
Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM
Analyst Price Target
No estimates available

9

S

7

W

0

O

0

T

SWOT Analysis

Bal Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
20 Jul, 2022 ICRA RATINGS
Bal Pharma Limited
Bal Pharma Limited: Rating Withdrawn
link
14 Mar, 2022 CRISIL RATINGS
Bal Pharma Limited
Bal Pharma Limited:Ratings Withdrawn
link
21 Dec, 2021 ICRA RATINGS
Bal Pharma Limited
Bal Pharma Limited: Ratings reaffirmed at [ICRA]BB+ / [ICRA]A4+; Outlook revised to positive from stable
link
13 Sep, 2021 ICRA RATINGS
Bal Pharma Limited
Bal Pharma Limited: Ratings upgraded to [ICRA]BB+(Stable)/ [ICRA]A4+ from [ICRA]BB (Stable)/ [ICRA]A4
link
15 Mar, 2021 ICRA RATINGS
Bal Pharma Limited
Bal Pharma Limited: Ratings reaffirmed; Outlook revised to Stable from Negative
link
03 Feb, 2021 CRISIL RATINGS
Bal Pharma Limited
Bal Pharma Limited:Suspension revoked, 'CRISIL BB / Stable / CRISIL A4+ ' assigned to Bank Debt
link
10 Aug, 2020 ICRA RATINGS
Bal Pharma Limited
Bal Pharma Limited - Update on material event; Long term rating downgraded to [ICRA]BB and short-term rating downgraded to [ICRA]A4; …
link
23 Aug, 2019 ICRA RATINGS
Bal Pharma Limited
Bal Pharma Limited - Update on material event; Long term rating downgraded to [ICRA]BB+ and short-term rating downgraded to [ICRA]A4+; …
link
06 Dec, 2018 ICRA RATINGS
Bal Pharma Limited
Bal Pharma Limited: Ratings reaffirmed
link
17 Oct, 2018 ICRA RATINGS
Bal Pharma Limited
Update on reason for delay in periodic surveillance
link
18 Jul, 2017 ICRA RATINGS
Bal Pharma Limited
ICRA reaffirms the [ICRA]BBB / [ICRA]A3+ ratings outstanding on the bank facilities of Bal Pharma Limited
link
20 Jun, 2017 ICRA RATINGS
Bal Pharma Limited
Update on reason for delay in periodic surveillance
link
All Credit Ratings
23 Sep, 2022 BSE INDIA
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Pre…
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Pre…
pdf link
07 Sep, 2022 BSE INDIA
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Pre…
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Pre…
pdf link
06 Sep, 2022 BSE INDIA
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Pre…
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Pre…
pdf link

Bal Pharma Ltd. FAQ

How is Bal Pharma Ltd. today?
Bal Pharma Ltd. today is trading in the green, and is up by 0.86% at 98.13.
Bal Pharma Ltd. is currently trading up 0.86% on an intraday basis. In the past week the stock fell -0.13%. stock has been up 11.30% in the past quarter and fell -14.41% in the past year. You can view this in the overview section.